Combination of Protein Coding and Noncoding Gene Expression as a Robust Prognostic Classifier in Stage I Lung Adenocarcinoma

Combination of Protein Coding and Noncoding Gene Expression as a Robust Prognostic Classifier in Stage I Lung Adenocarcinoma

Prognostic tests for patients with early-stage lung cancer may provide needed guidance on postoperative surveillance and therapeutic decisions. We used a novel strategy to develop and validate a prognostic classifier for early-stage lung cancer. Specifically, we focused on 42 genes with roles in lun...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autori principali:	Ichiro Akagi, Hirokazu Okayama, Aaron J. Schetter, Ana I. Robles, Takashi Kohno, Elise D. Bowman, Dickran Kazandjian, Judith A. Welsh, Naohide Oue, Motonobu Saito, Masao Miyashita, Eiji Uchida, Toshihiro Takizawa, Seiichi Takenoshita, Vidar Skaug, Steen Mollerup, Aage Haugen, Jun Yokota, Curtis C. Harris
Natura:	Artigo
Lingua:	inglese
Pubblicazione:	2013
Accesso online:	https://doi.org/10.1158/0008-5472.can-13-0031
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Combination of Protein Coding and Noncoding Gene Expression as a Robust Prognostic Classifier in Stage I Lung Adenocarcinoma
di: Akagi, Ichiro, et al.
Pubblicazione: (2013)

The association of microRNA expression with prognosis and progression in early stage, non small cell lung adenocarcinoma: a retrospective analysis of three cohorts
di: Saito, Motonobu, et al.
Pubblicazione: (2011)

The Association of MicroRNA Expression with Prognosis and Progression in Early-Stage, Non–Small Cell Lung Adenocarcinoma: A Retrospective Analysis of Three Cohorts
di: Motonobu Saito, et al.
Pubblicazione: (2011)

DNA methylation of the CYP1A1 enhancer is associated with smoking‐induced genetic alterations in human lung
di: Xavier Tekpli, et al.
Pubblicazione: (2011)

A Two-Gene Prognostic Classifier for Early-Stage Lung Squamous Cell Carcinoma in Multiple Large-Scale and Geographically Diverse Cohorts
di: Noro, Rintaro, et al.
Pubblicazione: (2016)

An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma based on mRNA, microRNA and DNA Methylation Biomarkers
di: Robles, Ana I., et al.
Pubblicazione: (2015)

The expression of four genes as a prognostic classifier for stage I lung adenocarcinoma in 12 independent cohorts
di: Okayama, Hirokazu, et al.
Pubblicazione: (2014)

NOS2 enhances KRAS-induced lung carcinogenesis, inflammation and microRNA-21 expression
di: Okayama, Hirokazu, et al.
Pubblicazione: (2012)

An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers
di: Ana I. Robles, et al.
Pubblicazione: (2015)

NOS2 enhances KRAS‐induced lung carcinogenesis, inflammation and microRNA‐21 expression
di: Hirokazu Okayama, et al.
Pubblicazione: (2012)

Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women
di: Susan Olivo‐Marston, et al.
Pubblicazione: (2010)

Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women
di: Olivo-Marston, Susan E., et al.
Pubblicazione: (2010)

Gene variants and lung cancer risk
di: Landvik, Nina E, et al.
Pubblicazione: (2010)

Loss of MKK3 and MK2 Copy Numbers in Non-Small Cell Lung Cancer
di: Samulin Erdem, Johanna, et al.
Pubblicazione: (2016)

Gene aberrations for precision medicine against lung adenocarcinoma
di: Saito, Motonobu, et al.
Pubblicazione: (2016)

Gene aberrations for precision medicine against lung adenocarcinoma
di: Motonobu Saito, et al.
Pubblicazione: (2016)

Importance of CYP1A1 and CYP1B1 in bioactivation of benzo[a]pyrene in human lung cell lines
di: Heidi Uppstad, et al.
Pubblicazione: (2009)

Association of a functional polymorphism in the promoter of the <i>MDM2</i> gene with risk of nonsmall cell lung cancer
di: Helge Lind, et al.
Pubblicazione: (2006)

Copy number variation, increased gene expression, and molecular mechanisms of neurofascin in lung cancer
di: Samulin Erdem, Johanna, et al.
Pubblicazione: (2017)

Polymorphisms of the interleukin‐1 β gene are associated with increased risk of non‐small cell lung cancer
di: Shanbeh Zienolddiny, et al.
Pubblicazione: (2004)

Effects of carbon nanotubes on intercellular communication and involvement of IL-1 genes
di: Arnoldussen, Yke Jildouw, et al.
Pubblicazione: (2016)

Multiple myeloma epidemiology and survival, a unique malignancy
di: Kazandjian, Dickran
Pubblicazione: (2016)

Multiple myeloma epidemiology and survival: A unique malignancy
di: Dickran Kazandjian
Pubblicazione: (2016)

CDX2 is involved in microRNA-associated inflammatory carcinogenesis in gastric cancer
di: Saito, Motonobu, et al.
Pubblicazione: (2017)

DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer
di: Xavier Tekpli, et al.
Pubblicazione: (2012)

A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers
di: Shanbeh Zienolddiny, et al.
Pubblicazione: (2008)

A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survival
di: Kazandjian, Dickran, et al.
Pubblicazione: (2016)

Delaying the Use of High-Dose Melphalan With Stem Cell Rescue in Multiple Myeloma is Ready for Primetime
di: Kazandjian, Dickran, et al.
Pubblicazione: (2019)

Diagnosed with myeloma before age 40
di: Landgren, Ola, et al.
Pubblicazione: (2021)

A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survival
di: Dickran Kazandjian, et al.
Pubblicazione: (2016)

Augmentation of antibody-dependent cellular cytotoxicity with defucosylated monoclonal antibodies in patients with GI-tract cancer
di: Nakajima, Takahiro, et al.
Pubblicazione: (2018)

Long-term Outcomes of Lower Rectal Cancer Patients Treated with Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection after Preoperative Radiotherapy or Chemoradiotherapy
di: Sakamoto, Wataru, et al.
Pubblicazione: (2021)

A Three-microRNA Signature Predicts Responses to Platinum-Based Doublet Chemotherapy in Patients with Lung Adenocarcinoma
di: Saito, Motonobu, et al.
Pubblicazione: (2014)

Polymorphisms of DNA repair genes and risk of non-small cell lung cancer
di: Shanbeh Zienolddiny, et al.
Pubblicazione: (2005)

KIF5B-RET fusions in lung adenocarcinoma
di: Kohno, Takashi, et al.
Pubblicazione: (2012)

KIF5B-RET fusions in lung adenocarcinoma
di: Takashi Kohno, et al.
Pubblicazione: (2012)

Overexpression of endoglin (CD105) is associated with recurrence in radically resected gastric cancer
di: KOYAMA, YOSHIHISA, et al.
Pubblicazione: (2010)

Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma
di: Aoto, Keita, et al.
Pubblicazione: (2018)

Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma
di: Keita Aoto, et al.
Pubblicazione: (2017)

Expression of circadian clock genes in human colorectal adenoma and carcinoma
di: Momma, Tomoyuki, et al.
Pubblicazione: (2017)